|
|
|
|
| LEADER |
04148nma a2201189 u 4500 |
| 001 |
EB002050985 |
| 003 |
EBX01000000000000001194651 |
| 005 |
00000000000000.0 |
| 007 |
cr||||||||||||||||||||| |
| 008 |
220822 ||| eng |
| 020 |
|
|
|a 9783036543826
|
| 020 |
|
|
|a books978-3-0365-4382-6
|
| 020 |
|
|
|a 9783036543819
|
| 100 |
1 |
|
|a Fernandes, Ana Sofia
|
| 245 |
0 |
0 |
|a Redox-Active Molecules as Therapeutic Agents
|h Elektronische Ressource
|
| 260 |
|
|
|a Basel
|b MDPI - Multidisciplinary Digital Publishing Institute
|c 2022
|
| 300 |
|
|
|a 1 electronic resource (266 p.)
|
| 653 |
|
|
|a N-acetyl cysteine
|
| 653 |
|
|
|a amniotic membrane-derived mesenchymal stem cell
|
| 653 |
|
|
|a carnosic acid
|
| 653 |
|
|
|a CD IGS rats
|
| 653 |
|
|
|a mitochondrial reactive oxygen species
|
| 653 |
|
|
|a glutathione peroxidase
|
| 653 |
|
|
|a cell cycle
|
| 653 |
|
|
|a conditioned medium
|
| 653 |
|
|
|a sildenafil
|
| 653 |
|
|
|a n/a
|
| 653 |
|
|
|a thiosulfate
|
| 653 |
|
|
|a inhibitors
|
| 653 |
|
|
|a withanolide
|
| 653 |
|
|
|a peroxiredoxin 3
|
| 653 |
|
|
|a redox signaling
|
| 653 |
|
|
|a glutathione reductase
|
| 653 |
|
|
|a antioxidants
|
| 653 |
|
|
|a systemic sclerosis
|
| 653 |
|
|
|a chemoresistance
|
| 653 |
|
|
|a selenium-enriched Streptococcus thermophilus
|
| 653 |
|
|
|a cisplatin
|
| 653 |
|
|
|a verbascoside
|
| 653 |
|
|
|a cyanidin
|
| 653 |
|
|
|a Rubus genus
|
| 653 |
|
|
|a BAPN
|
| 653 |
|
|
|a in vitro fertilization
|
| 653 |
|
|
|a OxPhos
|
| 653 |
|
|
|a cardiorenal syndrome
|
| 653 |
|
|
|a NRF2
|
| 653 |
|
|
|a SGK1
|
| 653 |
|
|
|a doxorubicin
|
| 653 |
|
|
|a bioactivity-based assays
|
| 653 |
|
|
|a H2S donors
|
| 653 |
|
|
|a non-small cell lung cancer
|
| 653 |
|
|
|a selenium-enriched Enterococcus faecium
|
| 653 |
|
|
|a E3330
|
| 653 |
|
|
|a lysyl-oxidase like 2
|
| 653 |
|
|
|a apoptosis
|
| 653 |
|
|
|a prostate cancer
|
| 653 |
|
|
|a thiostrepton
|
| 653 |
|
|
|a adipose-derived mesenchymal stem cell
|
| 653 |
|
|
|a breast cancer
|
| 653 |
|
|
|a assisted reproductive technology
|
| 653 |
|
|
|a hydrogen sulfide
|
| 653 |
|
|
|a hypercholesterolemia
|
| 653 |
|
|
|a reactive oxygen species
|
| 653 |
|
|
|a antioxidant capacity
|
| 653 |
|
|
|a nuclear factor erythroid 2-related factor 2 (Nrf2)
|
| 653 |
|
|
|a Biology, life sciences / bicssc
|
| 653 |
|
|
|a lactic acid bacteria
|
| 653 |
|
|
|a curcumin
|
| 653 |
|
|
|a (poly)phenols
|
| 653 |
|
|
|a GSH
|
| 653 |
|
|
|a cancer therapy
|
| 653 |
|
|
|a EMT
|
| 653 |
|
|
|a migration
|
| 653 |
|
|
|a lysyl-oxidase
|
| 653 |
|
|
|a cell invasion
|
| 653 |
|
|
|a pro-oxidant therapy
|
| 653 |
|
|
|a oxidative stress
|
| 653 |
|
|
|a yeast-based discovery platform
|
| 653 |
|
|
|a DNA damage
|
| 653 |
|
|
|a Cysteamine
|
| 653 |
|
|
|a ATF4
|
| 653 |
|
|
|a metastases
|
| 653 |
|
|
|a invasion
|
| 653 |
|
|
|a cytotoxicity
|
| 653 |
|
|
|a in vitro culture
|
| 653 |
|
|
|a apurinic/apyrimidinic endonuclease 1
|
| 653 |
|
|
|a Research and information: general / bicssc
|
| 653 |
|
|
|a metabolomics
|
| 653 |
|
|
|a embryo
|
| 653 |
|
|
|a KEAP1
|
| 700 |
1 |
|
|a Fernandes, Ana Sofia
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b DOAB
|a Directory of Open Access Books
|
| 500 |
|
|
|a Creative Commons (cc), https://creativecommons.org/licenses/by/4.0/
|
| 024 |
8 |
|
|a 10.3390/books978-3-0365-4382-6
|
| 856 |
4 |
2 |
|u https://directory.doabooks.org/handle/20.500.12854/87539
|z DOAB: description of the publication
|
| 856 |
4 |
0 |
|u https://www.mdpi.com/books/pdfview/book/5737
|7 0
|x Verlag
|3 Volltext
|
| 082 |
0 |
|
|a 000
|
| 082 |
0 |
|
|a 333
|
| 082 |
0 |
|
|a 304
|
| 082 |
0 |
|
|a 600
|
| 520 |
|
|
|a Oxidative stress and altered redox signaling have been described in a plethora of pathological conditions. Redox-active molecules can thus potentially be used to modulate the etiology/progression of such diseases. Recent advances in molecular biology and pharmacology have strengthened this area of research by providing novel mechanistic insights. This book compiles a collection of 13 articles, covering a range of topics from in vitro studies to clinical research, focused on the potential therapeutic effects of either natural or synthetic compounds, applicable to different redox-related diseases.
|